1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp. XNAS: RGEN
111.43 -2.09 (-1.84%)
635.9K
XNAS Volume

XNAS 08 Aug, 2025 5:30 PM (EDT)

Repligen Corp. - RGEN - stock price prediction, stock price target, analyst ratings from 21 analysts

Repligen Corp. has a share price target of US$ 180, revenue growth forecast of 14.5%, and profit growth estimate of 301.3% for FY25, based on top 21 analyst calls.